Options in Prophylactic Surgery to Prevent Ovarian Cancer in High-Risk Women: How New Hypotheses of Fallopian Tube Origin Influence Recommendations
In women at increased risk of developing ovarian cancer, risk-reducing salpingo-oophorectomy is the only intervention that has been shown to decrease mortality from ovarian cancer and is the standard of care for risk reduction. Prophylactic salpingectomy with delayed oophorectomy should be considered in high-risk premenopausal women in the setting of a clinical trial.
KeywordsSalpingectomy Oophorectomy BRCA Hereditary breast and ovarian cancer syndrome Ovarian cancer Fimbriectomy
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 1.National Cancer Institute. Surveillance, epidemiology, and end results program. SEER stat fact sheets: ovary cancer. http://seer.cancer.gov/statfacts/html/ovary.html. 2015.
- 5.National Comprehensive Cancer Network. NCCN Guidelines version 2.2015. Hereditary breast and/or ovarian cancer syndrome. 2015.Google Scholar
- 7.United States Preventative Services Task Force (USPSTF). BRCA-related Cancer: risk assessment, genetic counseling and genetic testing. December 2013.Google Scholar
- 11.•Finch A, Lubinski J, Moller P, Singer CF, Karlan B, Senter L, et al. Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. J Clin Oncol. 2014;32(15):1547–53. To date, this is the largest prospective study in BRCA mutation carriers that provides risk percentages of developing ovarian cancer at certain age intervals. It also provides risk reduction estimates on ovarian cancer mortality and all-cause mortality following oophorectomy.CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Lu KH, Skates S, Hernandez MA, Bedi D, Bevers T, Leeds L, et al. A 2-stage ovarian cancer screening strategy using the risk of ovarian cancer algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value. Cancer. 2013;119(9):3454–61.CrossRefPubMedPubMedCentralGoogle Scholar
- 16.•Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomized controlled trial. Lancet. 2015. doi:10.1016/S0140-6736(15)01224-6. This recently published trial shows that multimodal ovarian cancer screening using ROCA results in a mortality reduction in average risk postmenopausal women.Google Scholar
- 17.Greene MH, Piedmonte M, Alberts D, Gail M, Hensley M, Miner Z, et al. A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a gynecologic oncology group study. Cancer Epidemiol Biomarkers Prev. 2008;17(3):594–604.CrossRefPubMedPubMedCentralGoogle Scholar
- 22.Rebbeck TR, Friebel T, Wagner T, Lynch HT, Garber JE, Daly MB, et al. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE study group. J Clin Oncol. 2005;23(31):7804–10.CrossRefPubMedGoogle Scholar
- 34.•Falconer H, Yin L, Gronberg H, Altman D. Ovarian cancer risk after salpingectomy: a nationwide population-based study. J Natl Cancer Inst. 2015; 107(2). doi: 10.1093/jnci/dju410. This study provides evidence of the ovarian cancer risk reduction following bilateral salpingectomy in average-risk women.
- 38.Centre Oscar Lambret. Radical fimbriectomy for young BRCA mutation carriers. https://clinicaltrials.gov/ct2/show/NCT01608074?term=NCT01608074&rank=1. 2015.
- 39.University Medical Center Nijmegen. Early salpingectomy (tubectomy) with delayed oophorectomy in BRCA 1/2 gene mutation carriers (TUBA). https://clinicaltrials.gov/ct2/show/NCT02321228?term=NCT02321228&rank=1. 2015.
- 40.M.D. Anderson Cancer Center. Prophylactic salpingectomy with delayed oophorectomy. https://clinicaltrials.gov/ct2/show/NCT01907789?term=NCT01907789&rank=1. 2015.